Abstract 6360: A tumor agnostic composite gene expression signature identifies three groups of patients treated with immune checkpoint blockade with distinct clinical outcome
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Mehdi Lamkhioued, Guillaume Robert-Siegwald, Roxane Pommier, Deborah Tricoli, Camille Brodin, Valery Attignon, Nicolas Gadot, Severine Tabone-Eglinger, Fayette Jerome, Aurelie Swalduz, Isabelle Ray-Coquard, Eve-Marie Neidhardt, Clélia Coutzac, Loic Verlingue, Olivier Tredan, Jean-Yves Blay, Christophe Caux, Alain Viari, Nicolas Poirier, Aurore Morello, Isabelle Girault, Pierre Saintigny
Institutions: Centre Léon Bérard, OSE Immunotherapeutics (France)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409633590